Early Confirmed 2018 Speakers

  • Dr Vasee Moorthy, Acting Team Leader, Vaccine Development Initiative for Vaccine Research, Department of Immunization, Vaccines & Biologicals, WHO

  • Dr Peter Hotez, President of the Sabin Vaccine Institute & Dean of National School of Tropical Medicine, Baylor College of Medicine

  • Prof Stanley A. Plotkin, Emeritus Professor, University of Pennsylvania

  • Prof Myron M. Levine, Grollman Distinguished Professor, Assoc. Dean for Global Health, Vaccinology & Infectious Diseases, University of Maryland School of Medicine

  • Dr Basav Ghosh, Senior Director, Manufacturing Sciences and Technology, Pfizer

  • Dr Bruce Gellin, President of Global Immunization, Sabin Institute 

  • Rahul Singhvi, COO, Takeda

  • Hugh O’Dowd, CEO, Neon Therapeutics*

  • Dr Rick Bright, Deputy Assistant Secretary for Preparedness and Response & Director, BARDA

  • Dr Peter Kwong, Chief, Structural Biology Section, Vaccines Research Center, NIAID

  • Dr Roman Chicz, Associate Vice President and Global Head of External Research and Development, Sanofi Pasteur 

  • Dr Martin Moore, Associate Professor, Interim Director of Research, Pediatric Infectious Diseases, Emory Children's Center

  • Dr Alan Cross, Clinical Professor, University of Maryland

  • Dr Bruce Weniger, CAPT, USPHS/CDC (ret.) & International Professor, Research Institute for Health Sciences, Chiang Mai University*

  • Dr Duane Gubler, Emeritus Professor, Emerging Infectious Diseases Programme, DukeNUS Medical School

  • Dr Heidi Larson, Director of The Vaccine Confidence Project (VCP) & Associate Professor, Department of Infectious Disease Epidemiology, LSHTM

  • Dr Vu Truong, Founder, Chief Executive Officer, Aridis Pharmaceuticals

  • Dr Fred Ramsdell, VP of Research, Parker Institute 

  • Tim Cooke, Chief Executive Officer, Novadigm 

  • Dr Carl R. Alving, Chief, Laboratory of Adjuvant & Antigen Research, U.S. Military HIV Research Program, Walter Reed Army Institute of Research

  • Prof Walter A. Orenstein, Professor and Associate Director; Influenza Pathogenesis & Immunology Research Center, Emory Vaccine Center*

  • Prof Mathuram Santosham, Johns Hopkins University, Professor, Departments of International Health and Pediatrics, Director Emeritus, Center for American Indian Health*

  • Dr Biol. Sci. Alessandro Sette, Center Head, Division Head, and Professor Center for Infectious Disease, La Jolla

  • Dr Roy Baynes, Senior Vice President Global Clinical Development and Chief Medical Officer, Merck

  • Dr Paul Offit, Director of the Vaccine Education Centre, The Children’s Hospital of Philadelphia

Dr Pei-Yong Shi, I.H. Kempner Professor of Human Genetics, utmb Health

  • Wendy Saffell-Clemmer, Director Research, Baxter BioPharma Solutions

  • Prof Emanuele Montomoli, Professor at the Public Health University of Siena & CSO, VisMederi

  • Dr Barney S. Graham, Senior Investigator, Viral Pathogenesis Laboratory, VRC, NIAID

  • Bruno Speder, Head Clinical Regulatory Affairs & Consultancy, SGS Life Sciences

  • Dr Robert Schreiber, Andrew M. and Jane M. Bursky Distinguished Professor, Pathology and Immunology; Director, Bursky Center for Human Immunology and Immunotherapy Programs, Washington University in St. Louis

  • Dr Alison Deckhut Augustine, Chief, Basic Immunology Branch, NIAID/NIH

  • Dr Yan-ping Yang, Head of Bioprocess Research & Development North America, Sanofi Pasteur

  • Fred Moin Siyoi, Deputy Registrar, Pharmacy and Poisons Board, Nairobi, Kenya

  • Dr Michael Kalos, Chief Scientific Officer, Cancer Immunobiology, Eli Lilly

  • Ana Maria Henao-Restrepo, MD, Team Leader, Implementation Research, Initiative for Vaccine Research, Department of Immunization, Vaccines & Biological, WHO

  • Dr David L. Smith, Professor in the Department of Epidemiology, Johns Hopkins and the Center for Disease Dynamics, Economics & Policy, Washington, D.C

  • Dr Robert Reiner, Assistant Professor, Global Health, University of Washington 

  • Todd Black, Executive Director Infectious Diseases, Head Antibacterial and Antifungal Discovery, Merck

  • Peter Dull, Deputy Director, Integrated Clinical Vaccine Development, the Bill & Melinda Gates Foundation

  • Dr Justin Oritz, Affiliate Assistant Professor, Global Health, Affiliate Assistant Professor, Medicine Medical Officer, Initiative for Vaccine Research, World Health Organization

  • R.K.Suri, Senior Advisor & former Chief Executive-Biologicals, Panacea Biotec Ltd

  • Dr Drew Pardoll, Director, Bloomberg Kimmel Institute for Cancer Immunotherapy, Professor of Oncology, Johns Hopkins University

  • Prof Felix Rey, Head of Structural Biology, Institut Pasteur

  • Dr Walter Straus, Executive Director and Head, Scientific Affairs/ Vaccines, Merck

  • Dr Mark Papania, Medical Epidemiologist, CDC  

  • Dr Uwe D. Staerz, Chief Scientific Officer and Chairman, Board of Directors, Greffex

  • Dr Andrea Carfi, Senior Director, Antigen Design and Project Leader, Valera

  • Dr Peter Kwong, Chief, Structural Biology Section, Vaccines Research Center, NIAID

  • Dr Steve Projan, Senior Vice President of Innovative Medicines, Research and Development and Head of Infectious  Diseases and Vaccines, Medimmune

  • Dr Eszter Nagy, Co-Founder, Chief Scientific Officer, and Managing Director, Arsanis Biosciences GmbH

  • Sushma Shivaswamy, Vice President, Research and Development, Xbiotech*

  • Suryanarayana Sankuratri, Executive Director, Business Development and Licensing, Merck

  • Dr Rick Bright, Deputy Assistant Secretary for Preparedness and Response & Director, BARDA

  • Dr Derek O'Hagan, Global Head of Vaccine Chemistry and Formulation Research, GSK Vaccines

  • BT Slingsby, CEO, Global Health Innovative Technology (GHIT) Fund, Japan

  • Dr Jerome Kim, Director General, IVI

  • Michael Schjrader, Co-Founder and CEO, Vaxess Technologies, Inc.

  • Darin Zehrung, Program Advisor, PATH

  • Stephen Nagler, Executive Director, MedPro Investors LLC

  • Scott Halstead, Adjunct Professor, Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences 

  • Brad Gessner, Scientific Director, Association pour la Médicine Préventive (AMP) 

  • Stephen J. Savarino, Associate Vice President, Translational Sciences and Dengue R&D Leader, Sanofi Pasteur

  • Steve Whitehead, Senior Associate Scientist, NIAID*

  • Dr Ted Tsia, Takeda*

  • Dr Thomas W. Scott, Director and Professor of Entomology, Univeristy of California

  • Dr Ira Longini, Professor & Co-director, Center for Statistics and Quantitative Infectious Diseases (CSQUID) Emerging Pathogens Institute, University of Florida

  • Dr Saad Omer, Professor, Emory Vaccine Center; Global Health, Epidemiology, and Pediatrics; Emory University, Schools of Public Health & Medicine, Emory Vaccine Center, Emory University

  • Dr Neal Halsey, Professor, International Health, Global Disease Epidemiology and Control, Johns Hopkins Bloomberg School of Public Health

  • Dr Dan Salmon, Professor, Global Disease Epidemiology and Control, Institute for Vaccine Safety, Johns Hopkins

  • Dr Dorit Rubinstein Reiss, Professor of Law, University of California Hastings

  • James Cheyne, Independent Supply Chain Consultant

  • *Subject to final session confirmation

Dr Erich Tauber, CEO and Founder, Themis Bioscience

  • Dr Mazen Hassanain, Founder, SaudiVax

  • Maria Elena Bottazzi, Director of Product Development, Baylor College of Medicine

  • Dr Heinz Feldmann, Chief, Laboratory of Virology Chief, Disease Modeling and Transmission Section, NIAID, NIH

  • Dr Don Gerson, CEO, PnuVax

  • Dr Jorge Kalil, Former Director of the Butantan Institute & Senior Profession or Immunology at University of São Paulo’s Medical School and Heart Institute

  • Dr Karen Broder, Medical Officer, Immunization Safety Office, Centers for Disease Control and Prevention

  • Dr Marta Tomasi, Professor of Law, Pavia University 

  • Dr Jason Schwartz, Assistant Professor of Public Health Policy, Yale School of Public Health

  • Dr Margie Danchin, Senior Research Fellow, Vaccine and Immunization Research Group, Murdoch Children’s Research Institute

  • Dr Philip R. Dormitzer, MD, Vice President and CSO: Viral Vaccines, Pfizer Vaccine Research and Development

  • Dr Kena Swanson, Research Lead, RSV, Pfizer

  • Beate Schmoele-Thoma, Clinical Lead, RSV, Pfizer

  • Dr Giuseppe Ciaramella, CSO, Valera 

  • Dr Klaus Osterrieder - Managing Director, Institute of Virology, Free University of Berlin

  • Dr Elisabeth Erlacher-Vindel - Deputy Head of the Scientific and Technical Department of the World Organisation for Animal Health (OIE)

  • Dr Hari Pujar, Vice President Technical Development and Manufacturing, Moderna Therapeutics

  • Dr Ann Ginsberg, Chief Medical Officer, Aeras

  • Laurie Werner, Global Director BID Initiative, PATH 

  • Rebecca Coyle, Executive Director, America Immunization Registry Association


Get Involved At Immune Profiling World Congress


To Sponsor Or Exhibit

Oliver Breed
+44 20 7092 1156




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071